101 related articles for article (PubMed ID: 5762678)
1. A new and rapid determination of pyridinium aldoximes in blood and urine.
Groff WA; Ellin RI
Clin Chem; 1969 Jan; 15(1):72-83. PubMed ID: 5762678
[No Abstract] [Full Text] [Related]
2. High-performance liquid chromatographic analysis of imidazolium and pyridinium oximes in plasma and urine.
Shih ML; Smith JR; Salem GW
J Chromatogr; 1990 May; 527(2):371-9. PubMed ID: 2387884
[TBL] [Abstract][Full Text] [Related]
3. Toxogonin: blood levels and side effects after intramuscular administration in man.
Sidell FR; Groff WA
J Pharm Sci; 1970 Jun; 59(6):793-7. PubMed ID: 5423080
[No Abstract] [Full Text] [Related]
4. Analysis of pyridinium aldoximes - a chromatographic approach.
Csermely T; Kalász H; Petroianu GA; Kuca K; Darvas F; Ludányi K; Mudhafar AA; Tekes K
Curr Med Chem; 2008; 15(23):2401-18. PubMed ID: 18855669
[TBL] [Abstract][Full Text] [Related]
5. Passage of pyridinium oximes into human red cells.
Ellin RI; Groff WA; Sidell FR
Biochem Pharmacol; 1974 Oct; 23(19):2663-70. PubMed ID: 4417588
[No Abstract] [Full Text] [Related]
6. The movement of pyridinium aldoximes across the red cell membrane.
Keen TE
Aust J Exp Biol Med Sci; 1973 Oct; 51(5):643-53. PubMed ID: 4787503
[No Abstract] [Full Text] [Related]
7. [Reactivation of cholinesterase with pyridinium aldoximes during their combined covalent immobilization in polymeric hydrogels].
Osinkin IuA; Chupov VV; Platé NA
Dokl Akad Nauk; 1992; 327(3):397-400. PubMed ID: 1486350
[No Abstract] [Full Text] [Related]
8. A liquid chromatographic-mass spectrometric (LC-MS) method for the analysis of the bis-pyridinium oxime ICD-585 in plasma: application in a guinea pig model.
Capacio BR; Dusick B; Smith JR; McDonough JH; Shih TM
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1420-5. PubMed ID: 20044318
[TBL] [Abstract][Full Text] [Related]
9. Study on medicinal chemistry of K203 in wistar rats and beagle dogs.
Kalász H; Szegi P; Jánoki G; Balogh L; Pöstényi Z; Musilek K; Petroianu GA; Siddiq A; Tekes K
Curr Med Chem; 2013; 20(16):2137-44. PubMed ID: 23531217
[TBL] [Abstract][Full Text] [Related]
10. LC-MS/MS approaches for the assay of bis-quaternary pyridinium oximes used as AChE reactivators in biological matrices.
Voicu V; Albu F; Tache F; Musilek K; Kuca K; Medvedovici A
Bioanalysis; 2013 Apr; 5(7):793-809. PubMed ID: 23534424
[TBL] [Abstract][Full Text] [Related]
11. [Spectrophotometric determination of Toxogonin in the urine and blood].
Burger N; Smerić Z; Hankonyi V
Arh Hig Rada Toksikol; 1984 Mar; 35(1):11-5. PubMed ID: 6391422
[No Abstract] [Full Text] [Related]
12. Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection.
Igarashi K; Castagnoli N
J Chromatogr; 1992 Sep; 579(2):277-83. PubMed ID: 1429975
[TBL] [Abstract][Full Text] [Related]
13. The stability of pyridinium crosslinks in urine and serum.
Walne AJ; James IT; Perrett D
Clin Chim Acta; 1995 Aug; 240(1):95-7. PubMed ID: 8582064
[No Abstract] [Full Text] [Related]
14. Mini review on blood-brain barrier penetration of pyridinium aldoximes.
Kalász H; Nurulain SM; Veress G; Antus S; Darvas F; Adeghate E; Adem A; Hashemi F; Tekes K
J Appl Toxicol; 2015 Feb; 35(2):116-23. PubMed ID: 25291712
[TBL] [Abstract][Full Text] [Related]
15. Fluorimetric determination and pharmacokinetic studies of fazadinium bromide in dogs.
Pastorino AM
Arzneimittelforschung; 1978; 28(10):1728-30. PubMed ID: 39568
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier permeability in various parts of the central nervous system.
Aarseth P; Barstad JA
Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):434-42. PubMed ID: 5715414
[No Abstract] [Full Text] [Related]
17. The interaction of bis-pyridinium oximes with mouse brain muscarinic receptor.
Amitai G; Kloog Y; Balderman D; Sokolovsky M
Biochem Pharmacol; 1980 Feb; 29(4):483-8. PubMed ID: 7370045
[No Abstract] [Full Text] [Related]
18. [Metabolism of 3-hydroxy-5-(hydroxymethyl)-2-methylisonicetinaldoxime, 2-hydroxy-3-methoxybenzaldoxime and 4-hydroxy-5-methoxyisophthalic dioxime].
Pham-Huu-Chanh ; Chanvattey S; Patte J
Biochem Pharmacol; 1970 May; 19(5):1703-7. PubMed ID: 5513950
[No Abstract] [Full Text] [Related]
19. High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator.
Tekes K; Hasan MY; Sheen R; Kuca K; Petroianu G; Ludányi K; Kalász H
J Chromatogr A; 2006 Jul; 1122(1-2):84-7. PubMed ID: 16690067
[TBL] [Abstract][Full Text] [Related]
20. Identification of two metabolites of the cholinesterase reactivator HI-6 isolated from rat urine.
Ligtenstein DA; Wils ER; Kossen SP; Hulst AG
J Pharm Pharmacol; 1987 Jan; 39(1):17-23. PubMed ID: 2880978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]